Advanced Pharmacological Principles and Pathophysiology
Practice Exam questions and correct answers– Updated
2026 (Graded A+) instant download pdf
Subject: Nursing Pharmacology and Pathophysiology (NUR 210)
Subtopic: Advanced Pharmacokinetics, Pharmacodynamics, and Neurological/Autonomic
Pharmacology
Question 1: A 68-year-old male with a history of chronic kidney disease (CKD) Stage 3b and
chronic heart failure is prescribed digoxigenin therapy for rate control in atrial fibrillation.
Considering the age-related physiological changes and the patient's comorbidities, which
pharmacokinetic phase is most critically altered, requiring the nurse to monitor for profound
systemic toxicity?
A) Hepatic first-pass metabolism
B) Renal elimination and clearance
C) Gastrointestinal passive absorption
D) Plasma protein binding capacity
Correct Answer: B - Renal elimination and clearance Rationale: Age-related declines in
glomerular filtration rate (GFR), compounded by pre-existing Stage 3b chronic kidney
disease, drastically reduce the renal clearance of drugs that are primarily excreted
unchanged by the kidneys, such as digoxin. This leads to an increased elimination half-life
and a high risk of digitalis toxicity. Hepatic first-pass metabolism (A) may decrease with age
due to reduced hepatic blood flow, but it is not the primary route for digoxin clearance.
Gastrointestinal absorption (C) remains relatively stable or marginally altered in older adults
and does not dictate the major toxicity risk here. Plasma protein binding (D) is less critical for
digoxin compared to highly protein-bound drugs like warfarin, as digoxin binds primarily to
tissue receptors (Na+/K+-ATPase).
Question 2: An instructional designer is creating a simulation for NUR 210 students involving
a patient in cholinergic crisis secondary to an overdose of an acetylcholinesterase inhibitor.
Which clinical manifestation should the students be trained to recognize as a nicotinic
receptor overstimulation effect rather than a muscarinic receptor effect?
A) Profuse diaphoresis and lacrimation
B) Generalized muscle fasciculations and weakness
C) Severe bronchorrhea and bradycardia
D) Hyperactive bowel sounds and diarrhea
,Correct Answer: B - Generalized muscle fasciculations and weakness Rationale:
Acetylcholine stimulates both muscarinic and nicotinic receptors. Nicotinic receptors are
located at the neuromuscular junction of skeletal muscles; overstimulation leads to muscle
fasciculations, cramping, and eventual depolarizing neuromuscular blockade
(weakness/paralysis). Options A, C, and D are classic signs of muscarinic overstimulation,
often recalled by the acronym DUMBBELS (Diarrhea, Urination, Miosis, Bradycardia,
Bronchorrhea/Bronchospasm, Emesis, Lacrimation, Salivation/Sweating).
Question 3: A patient with a history of severe anaphylactic reactions to penicillin is admitted
with a complicated intra-abdominal infection. The provider orders an intravenous
cephalosporin. From a pathophysiological and pharmacological standpoint, what structural
component drives the potential cross-sensitivity between these two classes of
antimicrobials?
A) The thiazolidine ring system
B) The shared beta-lactam ring core
C) The acyl side-chain substitution
D) The dihydrothiazine ring configuration
Correct Answer: B - The shared beta-lactam ring core Rationale: The structural similarity
responsible for cross-sensitivity between penicillins and cephalosporins is the shared beta-
lactam ring core. If a patient exhibits a true IgE-mediated type I hypersensitivity reaction to
penicillins, there is an elevated risk of cross-reactivity with cephalosporins (especially first-
generation agents). The thiazolidine ring (A) is specific to penicillins, while the
dihydrothiazine ring (D) is specific to cephalosporins. Acyl side chains (C) modulate the
antibacterial spectrum and chemical stability but are secondary to the core ring structure
regarding primary class hypersensitivity.
Question 4: During a clinical rotation, a nurse evaluates a patient receiving a continuous
intravenous infusion of a potent loop diuretic. The patient's lab results demonstrate severe
hypokalemia and metabolic alkalosis. What is the precise molecular mechanism within the
renal tubule that precipitates this metabolic state?
A) Inhibition of the $Na^+/Cl^-$ symporter in the distal convoluted tubule
B) Blockade of the $Na^+/K^+/2Cl^-$ cotransporter in the thick ascending limb, increasing
distal sodium delivery and aldosterone-mediated $H^+$ and $K^+$ excretion
C) Antagonism of aldosterone receptors in the cortical collecting duct, wasting bicarbonate
ions
D) Competitive inhibition of carbonic anhydrase in the proximal convoluted tubule
,Correct Answer: B - Blockade of the $Na^+/K^+/2Cl^-$ cotransporter in the thick
ascending limb, increasing distal sodium delivery and aldosterone-mediated $H^+$ and
$K^+$ excretion Rationale: Loop diuretics inhibit the $Na^+/K^+/2Cl^-$ cotransporter in the
thick ascending limb of the loop of Henle. This results in massive delivery of sodium and
water to the distal segments of the nephron. The increased sodium delivery stimulates the
renin-angiotensin-aldosterone system (RAAS) and downstream principal and intercalated
cells in the collecting duct to reabsorb sodium in exchange for secreting potassium ($K^+$)
and hydrogen ($H^+$) ions into the urine, causing hypokalemia and hypokalemic metabolic
alkalosis. Option A describes thiazide diuretics. Option C describes potassium-sparing
diuretics, which cause hyperkalemia and metabolic acidosis. Option D describes carbonic
anhydrase inhibitors, which cause metabolic acidosis.
Question 5: A patient is prescribed a loading dose of an anticonvulsant medication. The
primary clinical justification for administering a loading dose of any pharmacological agent is
to circumvent which pharmacokinetic limitation?
A) The prolonged time required to reach a therapeutic steady-state plasma concentration
B) High first-pass hepatic extraction ratios
C) Rapid renal clearance and minimal volume of distribution
D) The variable rate of bioavailability associated with oral formulations
Correct Answer: A - The prolonged time required to reach a therapeutic steady-state
plasma concentration Rationale: It takes approximately 4 to 5 elimination half-lives
($t_{1/2}$) for a drug administered at a constant maintenance dose to reach steady-state
plasma concentrations. When an immediate therapeutic effect is required (such as
controlling active seizures), a large loading dose is given to rapidly achieve target
therapeutic concentrations, bypassing the delay. A loading dose does not alter first-pass
metabolism (B), renal clearance rates (C), or oral bioavailability profiles (D).
Question 6: A 42-year-old female patient with a history of pheochromocytoma is undergoing
pre-operative stabilization. She is prescribed phenoxybenzamine, an irreversible, non-
competitive alpha-adrenergic antagonist. How does a non-competitive antagonist alter the
pharmacodynamic profile of endogenous catecholamines (agonists) on a dose-response
curve?
A) It shifts the curve to the right, maintaining maximum efficacy but increasing the
$EC_{50}$
B) It shifts the curve to the left, increasing potency without altering efficacy
C) It depresses the maximal response (efficacy) of the agonist, regardless of increasing
agonist concentration
D) It increases both the maximum efficacy and potency through receptor upregulation
, Correct Answer: C - It depresses the maximal response (efficacy) of the agonist, regardless
of increasing agonist concentration Rationale: Non-competitive, irreversible antagonists
bind covalently or with extremely high affinity to the active receptor site or an allosteric site,
effectively removing those receptors from service. Because the agonist cannot displace a
non-competitive antagonist, increasing the concentration of the agonist (catecholamines)
cannot overcome the blockade. This reduces the maximal achievable response (maximal
efficacy), flattening the dose-response curve. Shifting the curve to the right (A) describes a
competitive, reversible antagonist.
Question 7: A nurse is monitoring a patient who has been taking high-dose prednisone for
an autoimmune flare-up over the past six months. The patient suddenly discontinues the
medication. Pathophysiologically, what is the most critical hazard associated with abrupt
cessation of long-term glucocorticoid therapy?
A) Hypernatremia and fluid volume excess due to mineralocorticoid rebound
B) Acute adrenal crisis resulting from prolonged secondary suppression of the hypothalamic-
pituitary-adrenal (HPA) axis
C) Immediate hepatic necrosis caused by upregulation of metabolic enzymes
D) Thyroid storm triggered by rapid shifts in systemic metabolic demands
Correct Answer: B - Acute adrenal crisis resulting from prolonged secondary suppression of
the hypothalamic-pituitary-adrenal (HPA) axis Rationale: Exogenous glucocorticoid
administration suppresses the secretion of Corticotropin-Releasing Hormone (CRH) from the
hypothalamus and Adrenocorticotropic Hormone (ACTH) from the anterior pituitary via
negative feedback loops. Prolonged suppression causes atrophy of the adrenal cortex. If the
drug is stopped abruptly, the atrophied adrenal glands cannot produce endogenous cortisol,
precipitating a life-threatening acute adrenal crisis (hypotension, hyponatremia,
hyperkalemia, hypoglycemia, and shock). It causes hyponatremia, not hypernatremia (A),
and does not result in hepatic necrosis (C) or thyroid storm (D).
Question 8: A 54-year-old male is initiated on transdermal nitroglycerin patches for the
management of stable angina pectoris. To mitigate the physiological phenomenon of
pharmacodynamic tolerance, what instruction must the nurse include in the patient
education plan?
A) Apply a second patch immediately if mild chest pain develops during physical exertion
B) Ensure the patch remains applied continuously for 24 hours before replacing it at the
same anatomical site
C) Remove the patch for a designated 10-to-12-hour period daily, typically overnight
D) Consume a high-sodium diet to preserve intravascular volume depletion caused by the
nitrate
Practice Exam questions and correct answers– Updated
2026 (Graded A+) instant download pdf
Subject: Nursing Pharmacology and Pathophysiology (NUR 210)
Subtopic: Advanced Pharmacokinetics, Pharmacodynamics, and Neurological/Autonomic
Pharmacology
Question 1: A 68-year-old male with a history of chronic kidney disease (CKD) Stage 3b and
chronic heart failure is prescribed digoxigenin therapy for rate control in atrial fibrillation.
Considering the age-related physiological changes and the patient's comorbidities, which
pharmacokinetic phase is most critically altered, requiring the nurse to monitor for profound
systemic toxicity?
A) Hepatic first-pass metabolism
B) Renal elimination and clearance
C) Gastrointestinal passive absorption
D) Plasma protein binding capacity
Correct Answer: B - Renal elimination and clearance Rationale: Age-related declines in
glomerular filtration rate (GFR), compounded by pre-existing Stage 3b chronic kidney
disease, drastically reduce the renal clearance of drugs that are primarily excreted
unchanged by the kidneys, such as digoxin. This leads to an increased elimination half-life
and a high risk of digitalis toxicity. Hepatic first-pass metabolism (A) may decrease with age
due to reduced hepatic blood flow, but it is not the primary route for digoxin clearance.
Gastrointestinal absorption (C) remains relatively stable or marginally altered in older adults
and does not dictate the major toxicity risk here. Plasma protein binding (D) is less critical for
digoxin compared to highly protein-bound drugs like warfarin, as digoxin binds primarily to
tissue receptors (Na+/K+-ATPase).
Question 2: An instructional designer is creating a simulation for NUR 210 students involving
a patient in cholinergic crisis secondary to an overdose of an acetylcholinesterase inhibitor.
Which clinical manifestation should the students be trained to recognize as a nicotinic
receptor overstimulation effect rather than a muscarinic receptor effect?
A) Profuse diaphoresis and lacrimation
B) Generalized muscle fasciculations and weakness
C) Severe bronchorrhea and bradycardia
D) Hyperactive bowel sounds and diarrhea
,Correct Answer: B - Generalized muscle fasciculations and weakness Rationale:
Acetylcholine stimulates both muscarinic and nicotinic receptors. Nicotinic receptors are
located at the neuromuscular junction of skeletal muscles; overstimulation leads to muscle
fasciculations, cramping, and eventual depolarizing neuromuscular blockade
(weakness/paralysis). Options A, C, and D are classic signs of muscarinic overstimulation,
often recalled by the acronym DUMBBELS (Diarrhea, Urination, Miosis, Bradycardia,
Bronchorrhea/Bronchospasm, Emesis, Lacrimation, Salivation/Sweating).
Question 3: A patient with a history of severe anaphylactic reactions to penicillin is admitted
with a complicated intra-abdominal infection. The provider orders an intravenous
cephalosporin. From a pathophysiological and pharmacological standpoint, what structural
component drives the potential cross-sensitivity between these two classes of
antimicrobials?
A) The thiazolidine ring system
B) The shared beta-lactam ring core
C) The acyl side-chain substitution
D) The dihydrothiazine ring configuration
Correct Answer: B - The shared beta-lactam ring core Rationale: The structural similarity
responsible for cross-sensitivity between penicillins and cephalosporins is the shared beta-
lactam ring core. If a patient exhibits a true IgE-mediated type I hypersensitivity reaction to
penicillins, there is an elevated risk of cross-reactivity with cephalosporins (especially first-
generation agents). The thiazolidine ring (A) is specific to penicillins, while the
dihydrothiazine ring (D) is specific to cephalosporins. Acyl side chains (C) modulate the
antibacterial spectrum and chemical stability but are secondary to the core ring structure
regarding primary class hypersensitivity.
Question 4: During a clinical rotation, a nurse evaluates a patient receiving a continuous
intravenous infusion of a potent loop diuretic. The patient's lab results demonstrate severe
hypokalemia and metabolic alkalosis. What is the precise molecular mechanism within the
renal tubule that precipitates this metabolic state?
A) Inhibition of the $Na^+/Cl^-$ symporter in the distal convoluted tubule
B) Blockade of the $Na^+/K^+/2Cl^-$ cotransporter in the thick ascending limb, increasing
distal sodium delivery and aldosterone-mediated $H^+$ and $K^+$ excretion
C) Antagonism of aldosterone receptors in the cortical collecting duct, wasting bicarbonate
ions
D) Competitive inhibition of carbonic anhydrase in the proximal convoluted tubule
,Correct Answer: B - Blockade of the $Na^+/K^+/2Cl^-$ cotransporter in the thick
ascending limb, increasing distal sodium delivery and aldosterone-mediated $H^+$ and
$K^+$ excretion Rationale: Loop diuretics inhibit the $Na^+/K^+/2Cl^-$ cotransporter in the
thick ascending limb of the loop of Henle. This results in massive delivery of sodium and
water to the distal segments of the nephron. The increased sodium delivery stimulates the
renin-angiotensin-aldosterone system (RAAS) and downstream principal and intercalated
cells in the collecting duct to reabsorb sodium in exchange for secreting potassium ($K^+$)
and hydrogen ($H^+$) ions into the urine, causing hypokalemia and hypokalemic metabolic
alkalosis. Option A describes thiazide diuretics. Option C describes potassium-sparing
diuretics, which cause hyperkalemia and metabolic acidosis. Option D describes carbonic
anhydrase inhibitors, which cause metabolic acidosis.
Question 5: A patient is prescribed a loading dose of an anticonvulsant medication. The
primary clinical justification for administering a loading dose of any pharmacological agent is
to circumvent which pharmacokinetic limitation?
A) The prolonged time required to reach a therapeutic steady-state plasma concentration
B) High first-pass hepatic extraction ratios
C) Rapid renal clearance and minimal volume of distribution
D) The variable rate of bioavailability associated with oral formulations
Correct Answer: A - The prolonged time required to reach a therapeutic steady-state
plasma concentration Rationale: It takes approximately 4 to 5 elimination half-lives
($t_{1/2}$) for a drug administered at a constant maintenance dose to reach steady-state
plasma concentrations. When an immediate therapeutic effect is required (such as
controlling active seizures), a large loading dose is given to rapidly achieve target
therapeutic concentrations, bypassing the delay. A loading dose does not alter first-pass
metabolism (B), renal clearance rates (C), or oral bioavailability profiles (D).
Question 6: A 42-year-old female patient with a history of pheochromocytoma is undergoing
pre-operative stabilization. She is prescribed phenoxybenzamine, an irreversible, non-
competitive alpha-adrenergic antagonist. How does a non-competitive antagonist alter the
pharmacodynamic profile of endogenous catecholamines (agonists) on a dose-response
curve?
A) It shifts the curve to the right, maintaining maximum efficacy but increasing the
$EC_{50}$
B) It shifts the curve to the left, increasing potency without altering efficacy
C) It depresses the maximal response (efficacy) of the agonist, regardless of increasing
agonist concentration
D) It increases both the maximum efficacy and potency through receptor upregulation
, Correct Answer: C - It depresses the maximal response (efficacy) of the agonist, regardless
of increasing agonist concentration Rationale: Non-competitive, irreversible antagonists
bind covalently or with extremely high affinity to the active receptor site or an allosteric site,
effectively removing those receptors from service. Because the agonist cannot displace a
non-competitive antagonist, increasing the concentration of the agonist (catecholamines)
cannot overcome the blockade. This reduces the maximal achievable response (maximal
efficacy), flattening the dose-response curve. Shifting the curve to the right (A) describes a
competitive, reversible antagonist.
Question 7: A nurse is monitoring a patient who has been taking high-dose prednisone for
an autoimmune flare-up over the past six months. The patient suddenly discontinues the
medication. Pathophysiologically, what is the most critical hazard associated with abrupt
cessation of long-term glucocorticoid therapy?
A) Hypernatremia and fluid volume excess due to mineralocorticoid rebound
B) Acute adrenal crisis resulting from prolonged secondary suppression of the hypothalamic-
pituitary-adrenal (HPA) axis
C) Immediate hepatic necrosis caused by upregulation of metabolic enzymes
D) Thyroid storm triggered by rapid shifts in systemic metabolic demands
Correct Answer: B - Acute adrenal crisis resulting from prolonged secondary suppression of
the hypothalamic-pituitary-adrenal (HPA) axis Rationale: Exogenous glucocorticoid
administration suppresses the secretion of Corticotropin-Releasing Hormone (CRH) from the
hypothalamus and Adrenocorticotropic Hormone (ACTH) from the anterior pituitary via
negative feedback loops. Prolonged suppression causes atrophy of the adrenal cortex. If the
drug is stopped abruptly, the atrophied adrenal glands cannot produce endogenous cortisol,
precipitating a life-threatening acute adrenal crisis (hypotension, hyponatremia,
hyperkalemia, hypoglycemia, and shock). It causes hyponatremia, not hypernatremia (A),
and does not result in hepatic necrosis (C) or thyroid storm (D).
Question 8: A 54-year-old male is initiated on transdermal nitroglycerin patches for the
management of stable angina pectoris. To mitigate the physiological phenomenon of
pharmacodynamic tolerance, what instruction must the nurse include in the patient
education plan?
A) Apply a second patch immediately if mild chest pain develops during physical exertion
B) Ensure the patch remains applied continuously for 24 hours before replacing it at the
same anatomical site
C) Remove the patch for a designated 10-to-12-hour period daily, typically overnight
D) Consume a high-sodium diet to preserve intravascular volume depletion caused by the
nitrate
